Lecture Notes

**Lecture Coverage:**
- Cancer Immunoediting
- Cancer Immunosurveillance
- Cancer Immune Escape

---
#### **Cancer Immunoediting**
- Dynamic Process explaining the dual role of the immune system suppressing and/or promoting tumor growth
	- Made up of 3 Phases:

| Phase       | Description           |
| ----------- | --------------------- |
| Elimination | Surveillance > Escape |
| Equilibrium | Surveillance ≈ Escape |
| Escape      | Surveillance < Escape |


#### **Cancer Immunosurveillance**
- Combination of Anatomical Barriers, Innate & Adaptive immunities

**Innate Immunity**

|                    Cell Type                     |                         Receptors                          |                                                                            Means of Tumor Recognition                                                                            | Function                                                                                                                                                                                                                                                   |
| :----------------------------------------------: | :--------------------------------------------------------: | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------: | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|     <abbr Title="Dendritic Cell">DC</abbr>s      | <br><abbr Title="Pattern Recognition Receptors">PRR</abbr> | <br>Tumor-derived <abbr Title="Damage-Associated Molecular Patterns">DAMP</abbr>s (e.g. <abbr Title="Heat Shock Proteins">HSP</abbr> & <abbr Title="Mitochondrial">mt</abbr>DNA) | Phagocytosis & Absorb Antigen<br>Present Antigen to CD4<sup>+</sup> & CD8<sup>+</sup> T Cells                                                                                                                                                              |
|                   Macrophages                    |                             ^                              |                                                                                        ^                                                                                         | Phagocytosis                                                                                                                                                                                                                                               |
| <br><abbr Title="Natural Killer">NK</abbr> Cells |                         <br>NKG2D                          |                                                  <br><abbr Title="MHC I Polypeptide-Related Sequence A & B">MICA & MICB</abbr>                                                   | Induce Lysis: <abbr Title="Interferon">IFN-γ</abbr>, Granzyme B & Perforin<br>Induce Apoptosis: <abbr Title="TNF (Tumor Necrosis Factor) Related Apoptosis-Inducing Ligand">TRAIL</abbr><br><abbr Title="Antibody Dependent Cell Cytotoxicity">ADCC</abbr> |

**Adaptive Immunity**
- Antigen Specific Recognition, (In)direct Killing, Long-Term Memory Protection

|         Cell Type          |                              <                               | Means of Tumor Recognition | Function                                                                                                           |
| :------------------------: | :----------------------------------------------------------: | :------------------------: | ------------------------------------------------------------------------------------------------------------------ |
|  <br>Conventional T Cells  |         CD4<sup>+</sup><br><font size=2>(Th1)</font>         |            APC             | CD8<sup>+</sup> Activation, Expansion & Memory<br>- Through Cytokines (IL-2) & Co-Stimulatory Signals (CD40-CD40L) |
|             ^              |         CD4<sup>+</sup><br><font size=2>(All)</font>         |            APC             | Differentiate into effector subsets upon Activation<br>Ensure Optimal Responses by other Lymphocytes               |
|             ^              |                       CD8<sup>+</sup>                        |         APC / Th1          | Direct Cytotoxicity → <br>Differentiate into Memory Cell / Functional Exhaustion                                   |
| <br>Unconventional T Cells | <abbr Title="Invariant Natural Killer T Cells">(i)NKT</abbr> |      APC / Tumor CD1d      | Tumor Cytolysis (More Effective on Metastasis)<br>Regulation of other Lymphocytes                                  |
|             ^              |                             γδT                              |            APC             | Broad Functional Plasticity (e.g. Direct Cytotoxicity)                                                             |
|        <br>B Cells         |                           All<br>                            |            APC             |                                                                                                                    |
|             ^              |                            Plasma                            |            APC             | Secrete IgG1 Antibodies → Facilitate ADCC & Phagocytosis                                                           |
